share_log

ナノMRNA---千寿製薬と眼科疾患を対象にmRNA創薬に関する共同研究契約を締結

Nano mRNA has signed a joint research agreement with Senshu Pharmaceutical to develop mRNA drugs for ophthalmic diseases.

Fisco Japan ·  Aug 14 08:31

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment